AR051767A1 - Derivados de quinolina e isoquinolina 5-sustituidos un procedimiento para su preparacion y su uso como inhibidores de la inflamacion - Google Patents

Derivados de quinolina e isoquinolina 5-sustituidos un procedimiento para su preparacion y su uso como inhibidores de la inflamacion

Info

Publication number
AR051767A1
AR051767A1 ARP050104767A ARP050104767A AR051767A1 AR 051767 A1 AR051767 A1 AR 051767A1 AR P050104767 A ARP050104767 A AR P050104767A AR P050104767 A ARP050104767 A AR P050104767A AR 051767 A1 AR051767 A1 AR 051767A1
Authority
AR
Argentina
Prior art keywords
procedure
preparation
substituted quinoline
isoquinoline derivatives
inflammation inhibitors
Prior art date
Application number
ARP050104767A
Other languages
English (en)
Inventor
Stefan Jaroch
Werner Skuballa
Hartmut Rehwinkel
Norbert Schmees
Heike Schacke
Jan Hubner
Orlin Petrov
Matthias Schneider
C Dinter
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102005020331A external-priority patent/DE102005020331A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of AR051767A1 publication Critical patent/AR051767A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Reivindicacion 1: Compuestos de la formula generales (1) o (2) en donde R1 y R2 son, de modo independiente, un átomo de H, un grupo alquilo C1-3, un átomo de halogeno, un grupo ciano, un gripo alcoxi C1-3 o un grupo hidroxi, así como sus racematos o estereoisomeros separados y sus sales o profármacos fisiologicamente tolerables.
ARP050104767A 2004-11-12 2005-11-14 Derivados de quinolina e isoquinolina 5-sustituidos un procedimiento para su preparacion y su uso como inhibidores de la inflamacion AR051767A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004055633A DE102004055633A1 (de) 2004-11-12 2004-11-12 5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
DE102005020331A DE102005020331A1 (de) 2005-04-26 2005-04-26 5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer

Publications (1)

Publication Number Publication Date
AR051767A1 true AR051767A1 (es) 2007-02-07

Family

ID=35613753

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104767A AR051767A1 (es) 2004-11-12 2005-11-14 Derivados de quinolina e isoquinolina 5-sustituidos un procedimiento para su preparacion y su uso como inhibidores de la inflamacion

Country Status (31)

Country Link
EP (1) EP1844039B1 (es)
JP (1) JP4460608B2 (es)
KR (1) KR101168462B1 (es)
CN (1) CN101124220B (es)
AR (1) AR051767A1 (es)
AU (1) AU2005303926B2 (es)
BR (1) BRPI0517797A (es)
CA (1) CA2586689C (es)
CY (1) CY1110520T1 (es)
DE (2) DE102004055633A1 (es)
DK (1) DK1844039T3 (es)
EA (1) EA013076B1 (es)
ES (1) ES2329599T3 (es)
GT (1) GT200500330A (es)
HK (1) HK1112243A1 (es)
HR (1) HRP20090509T1 (es)
IL (1) IL182933A (es)
ME (2) MEP13608A (es)
MX (1) MX2007005736A (es)
MY (1) MY141780A (es)
NO (1) NO332405B1 (es)
NZ (1) NZ555064A (es)
PA (1) PA8652701A1 (es)
PE (1) PE20061052A1 (es)
PL (1) PL1844039T3 (es)
PT (1) PT1844039E (es)
RS (2) RS51161B (es)
SI (1) SI1844039T1 (es)
TW (1) TWI311559B (es)
UY (1) UY29213A1 (es)
WO (1) WO2006050998A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297700B2 (en) 2005-03-24 2007-11-20 Renovis, Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
TWI464148B (zh) 2006-03-16 2014-12-11 Evotec Us Inc 作為ｐ２ｘ7調節劑之雙環雜芳基化合物與其用途
CN101484187B (zh) * 2006-07-07 2012-12-26 博士伦公司 包含解离的糖皮质激素受体激动剂和免疫抑制剂的用于治疗干眼症的组合物
ES2403512T3 (es) * 2006-08-07 2013-05-20 Bausch & Lomb Incorporated Composiciones y métodos para tratar, controlar, reducir, o mejorar infecciones y sus secuelas
MX2009001333A (es) * 2006-08-07 2009-02-13 Bausch & Lomb Composiciones y metodos para tratar, reducir, mejorar o aliviar enfermedades oftalmicas del segmento posterior.
WO2008027796A2 (en) * 2006-08-31 2008-03-06 Bausch & Lomb Incorporated Compositions and methods for treating or preventing glaucoma or progression thereof
PT2061444E (pt) * 2006-09-11 2011-07-08 Bausch & Lomb Composições e métodos de tratamento, controlo, redução, melhoramento ou prevenção de alergias
US20110105559A1 (en) * 2006-09-11 2011-05-05 Rohrs Brian R Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy
US20110104159A1 (en) * 2006-09-11 2011-05-05 Rohrs Brian R Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
MX2009004904A (es) * 2006-11-09 2009-05-19 Bausch & Lomb Sintesis de estereoisomeros seleccionados de ciertos alcoholes sustituidos.
US8071796B2 (en) * 2007-04-18 2011-12-06 Intendis Gmbh Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof
EP1982976A1 (en) * 2007-04-18 2008-10-22 Intendis GmbH Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof
EP2016935A1 (en) * 2007-07-09 2009-01-21 Intendis GmbH Pharmaceutical composition for topical application of poorly soluble compounds
US20090042936A1 (en) * 2007-08-10 2009-02-12 Ward Keith W Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation
US20090087443A1 (en) * 2007-09-27 2009-04-02 Bartels Stephen P Pharmacological Adjunctive Treatment Associated with Glaucoma Filtration Surgery
WO2009058585A2 (en) * 2007-11-01 2009-05-07 Bausch & Lomb Incorporated Non-aqueous water-miscible materials as vehicles for drug delivery
US20110077270A1 (en) * 2009-04-21 2011-03-31 Pfeffer Bruce A Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
CN101983961B (zh) * 2010-11-24 2012-05-09 浙江启明生化科技有限公司 5-氨基-2-甲基喹啉的制备方法
US20120316199A1 (en) 2011-06-07 2012-12-13 Ward Keith W Compositions and methods for treating, controlling, reducing, or ameliorating inflammatory pain
WO2017137375A1 (en) 2016-02-12 2017-08-17 Bayer Animal Health Gmbh Mapracorat for use in the treatment of canine dermatitis
CN106800493B (zh) * 2017-01-16 2020-06-30 宜昌尚诺德生物医药科技有限公司 一种芳硝基还原为芳胺的方法
SG11202107075RA (en) 2019-01-22 2021-08-30 Akribes Biomedical Gmbh Selective glucocorticoid receptor modifiers for treating impaired skin wound healing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4041482A1 (de) * 1990-12-22 1992-06-25 Boehringer Ingelheim Kg Neue pharmazeutische verwendung carbocyclisch und heterocyclisch annelierter dihydropyridine
KR100224135B1 (ko) * 1993-01-28 1999-10-15 다께다 구니오 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도
RU2127271C1 (ru) * 1997-03-13 1999-03-10 Пермская государственная фармацевтическая академия 5-нитрофурфурилиденгидразид 2-хлор-5,6,7,8,-тетрагидрохинолин-4-карбоновой кислоты, обладающий антимикробной активностью
UA73492C2 (en) * 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
DE10215316C1 (de) * 2002-04-02 2003-12-18 Schering Ag Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
CA2512257A1 (en) * 2003-01-03 2004-07-29 Boehringer Ingelheim Pharmaceuticals, Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
US20040224992A1 (en) * 2003-02-27 2004-11-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7179919B2 (en) * 2004-03-18 2007-02-20 Boehringer Ingelheim Pharmaceuticals, Inc. Stereoselective synthesis of certain trifluoromethyl-substituted alcohols

Also Published As

Publication number Publication date
AU2005303926B2 (en) 2011-05-19
EA200700982A1 (ru) 2007-10-26
IL182933A0 (en) 2007-09-20
DK1844039T3 (da) 2009-11-09
CY1110520T1 (el) 2015-04-29
MX2007005736A (es) 2007-09-07
EA013076B1 (ru) 2010-02-26
JP2008519803A (ja) 2008-06-12
CN101124220A (zh) 2008-02-13
IL182933A (en) 2011-10-31
PT1844039E (pt) 2009-10-19
KR20070084192A (ko) 2007-08-24
DE502005007725D1 (de) 2009-08-27
BRPI0517797A (pt) 2008-10-21
HRP20090509T1 (hr) 2009-11-30
NO332405B1 (no) 2012-09-10
DE102004055633A1 (de) 2006-05-18
NZ555064A (en) 2009-09-25
RS51161B (sr) 2010-10-31
TW200640913A (en) 2006-12-01
CA2586689C (en) 2012-04-17
EP1844039A1 (de) 2007-10-17
ME00155B (me) 2010-10-10
EP1844039B1 (de) 2009-07-15
JP4460608B2 (ja) 2010-05-12
PE20061052A1 (es) 2006-11-08
HK1112243A1 (en) 2008-08-29
PA8652701A1 (es) 2006-07-03
WO2006050998A1 (de) 2006-05-18
UY29213A1 (es) 2006-05-31
TWI311559B (en) 2009-07-01
SI1844039T1 (sl) 2009-12-31
MY141780A (en) 2010-06-30
GT200500330A (es) 2006-09-21
MEP13608A (en) 2010-06-10
RS20070205A (en) 2008-11-28
NO20072963L (no) 2007-08-03
PL1844039T3 (pl) 2009-12-31
AU2005303926A1 (en) 2006-05-18
ES2329599T3 (es) 2009-11-27
CA2586689A1 (en) 2006-05-18
CN101124220B (zh) 2012-04-25
KR101168462B1 (ko) 2012-07-27

Similar Documents

Publication Publication Date Title
AR051767A1 (es) Derivados de quinolina e isoquinolina 5-sustituidos un procedimiento para su preparacion y su uso como inhibidores de la inflamacion
ECSP045399A (es) Derivados de quinolina e isoquinolina, un método para su preparación y su uso como inhibidores de la inflamación
CR8530A (es) Intermediarios de quinolona como inhibidores de receptores de tirosina quinasas y la sintesis de los mismos
CR20140215A (es) Ciclopenta (d) pirimidinas como inhibidores de la proteina cinasa akt
PE20060525A1 (es) Compuestos heterociclicos como inhibidores de cetp
UY32296A (es) Nuevos compuestos
EP2597088A4 (en) P2X4 Receptor Antagonists
ATE404536T1 (de) Substituierte chinolinderivate als inhibitoren von mitotischem kinesin
NO20061317L (no) Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
EA200700931A1 (ru) Новые производные дикарбоновых кислот
UA109525C2 (xx) Алкіламідна сполука і її застосування
TW200637539A (en) CTGF inhibitors
BRPI0508102A (pt) inibidores de caspase e usos dos mesmos
BRPI0518613A2 (pt) compostos, composiÇço farmacÊutica, mÉtodo de preparar uma composiÇço, e, uso de um composto
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
ATE488510T1 (de) Heterocyclische derivate, deren herstellung und therapeutische verwendung
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
BR112012030833A2 (pt) composto orgânico novo e dispositivo orgânico de emissão de luz que inclui o mesmo
PL1845780T3 (pl) Zastosowanie pochodnych metylofenidatu
EA200970497A1 (ru) Производные пиррола, их получение и их применение в терапии
DE602006014997D1 (de) Diaryltriazolmethylamin-derivate sowie ihre herstellung und therapeutische verwendung
EA200600601A1 (ru) Производные аминопиридина в качестве ингибиторов индуцируемой no-синтазы
EA200501247A1 (ru) Ингибитор белка резистентности рака молочной железы (bcrp)
BR0110490B1 (pt) agentes de tingimento contendo derivados de n-heteroarilmetil-m-fenilenodiamina para fibras de queratina bem como novos derivados de n-heteroarilmetil-m-fenilenodiamina.
GT200800296A (es) Derivados de ácido fenilacético

Legal Events

Date Code Title Description
FA Abandonment or withdrawal